S
Scilex Holding Company (SCLX)
NCM – Real vaqt narxi. Valyuta: USD
7.11
+0.02 (0.28%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
7.09
-0.02 (-0.21%)
Bozordan keyin: Jun 26, 2026, 7:19 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
7.11
+0.02 (0.28%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
7.09
-0.02 (-0.21%)
Bozordan keyin: Jun 26, 2026, 7:19 PM EDT
Scilex Holding Company kompaniyasi o'tkir va surunkali og'riqlarni davolash uchun opioid bo'lmagan og'riq qoldiruvchi vositalarni sotib olish, ishlab chiqish va tijoratlashtirishga qaratilgan. Uning tijoratlashtirilgan mahsulotlari orasida ZTlido (lidokainli topikal tizim) 1,8% (ZTlido) mavjud bo'lib, bu postherpetic nevralgiya (PHN) bilan bog'liq nevropatik og'riqni engillashtirish uchun retsept bo'yicha beriladigan lidokainli topikal mahsulotdir, bu esa post-shingles nerv og'rig'ining bir shaklidir; ELYXYB - kattalardagi migrenni aura bilan yoki aulasiz o'tkir davolash uchun tayyor, ichishga mo'ljallangan eritma; va GLOPERBA - kattalardagi podagra xurujlarini oldini olish uchun ko'rsatilgan podagaga qarshi dori kolxitsinning suyuq, og'iz orqali yuboriladigan shakli. Kompaniya, shuningdek, uchta mahsulot nomzodini ishlab chiqmoqda, jumladan SP-102 (10 mg, deksametazon natriy fosfatli yopishqoq gel - SEMDEXA) - epidural in'ektsiyalar uchun ishlatiladigan kortikosteroidning yangi yopishqoq gel formulasi, bu bel-dumg'aza radikulyar og'rig'i yoki siyatikani davolash uchun 3-bosqichli tadqiqotni yakunlagan; SP-103 (lidokainli topikal tizim) 5,4% - surunkali bo'yin va bel og'rig'ini (LBP) davolash uchun ZTlido formulasi, bu 2-bosqichli sinovni yakunlagan; va SP-104 (4,5 mg kam dozali naltrekson gidroxlorid kechiktirilgan kapsulalari) - fibromiyalni davolash uchun 1-bosqichli sinovlarni yakunlagan kam dozali, kechiktirilgan naltrekson gidroxloridning yangi shakli. U Oishi va Itochu bilan lidokainli plastir mahsulotlarini, shu jumladan ZTlido va SP-103ni ishlab chiqish bo'yicha; Lifecore Biomedical, LLC bilan SEMDEXA uchun klinik sinov materiallarini ishlab chiqarish va rivojlantirish xizmatlari bo'yicha; va SP-104ning klinik ta'minotini ishlab chiqish, sinovdan o'tkazish va ishlab chiqarishni amalga oshiruvchi Tulex Master bilan kelishuvga ega. Scilex Holding Company Palo Alto, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Dmitri V. Lissin M.D. | Senior VP of Clinical Development and Medical Affairs & Interim Chief Medical Officer |
| Dr. Henry H. Ji Ph.D. | CEO, President & Executive Chairman |
| Dr. Suketu D. Desai Ph.D. | Interim Chief Technical Officer & Senior VP |
| Mr. Stephen Ma | Senior VP, CFO, COO, Corporate Secretary & Director |
| Mr. Suresh K. Khemani | Senior VP, Chief Commercial Officer & GM of Scilex Pharma |
| Ms. Gigi DeGuzman | VP & Chief People Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-24 | 8-K | sclx-20260624.htm |
| 2026-06-02 | S-3 | d279959ds3.htm |
| 2026-05-20 | 10-Q | sclx-20260331.htm |
| 2026-05-15 | NT 10-Q | scilex_nt_10q_2026.htm |
| 2026-05-11 | 8-K | sclx-20260511.htm |
| 2026-05-05 | DEFA14A | d298016ddefa14a.htm |
| 2026-05-05 | 8-K | sclx-20260504.htm |
| 2026-04-30 | DEF 14A | d146109ddef14a.htm |
| 2026-04-28 | 8-K | sclx-20260426.htm |
| 2026-04-16 | S-3 | d897596ds3.htm |